SMARCA1 and neoplasm: These findings not only expand the mechanistic repertoire of SWI/SNF complexes in hepatocarcinogenesis but also highlight the therapeutic potential of pro‐senescence agents targeting nucleotide metabolism in SWI/SNF‐mutant tumours.